Article
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
The EMBO journal - 1 Sept 2020
Hegde Ramanath Narayana, Chiki Anass, Petricca Lara, Martufi Paola, Arbez Nicolas, Mouchiroud Laurent, Auwerx Johan, Landles Christian, Bates Gillian P, Singh-Bains Malvindar K, Dragunow Mike, Curtis Maurice A, Faull Richard Lm, Ross Christopher A, Caricasole Andrea, Lashuel Hilal A
Abstract excerpt
Phosphorylation of the N-terminal domain of the huntingtin (HTT) protein has emerged as an important regulator of its localization, structure, aggregation, clearance and toxicity. However, validation of the effect of bona fide phosphorylation in vivo and assessing the therapeutic potential of targeting phosphorylation for the treatment of Huntington's disease (HD) require the identification of the enzymes that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
